Biotechnology stocks
1,443 listed biotechnology companies, ordered by market capitalisation, inside the Health Care sector. Every one has a free page with its price history, key figures and Tweenvest factor scores.
| Company | Market cap | Price | Day |
|---|---|---|---|
| Veracyte, Inc.NasdaqGM: VCYT | $3.54B | $44.04 | +6.20% |
| Zealand Pharma A/SCPSE: ZEAL | $3.48B | Dkr326.90 | +5.66% |
| uniQure N.V.NasdaqGS: QURE | $3.36B | $51.05 | +5.54% |
| NewAmsterdam Pharma Company N.V.NasdaqGM: NAMS | $3.33B | $27.34 | -1.90% |
| Immunome, Inc.NasdaqCM: IMNM | $3.24B | $29.39 | +3.03% |
| Celldex Therapeutics, Inc.NasdaqCM: CLDX | $3.24B | $41.22 | +1.60% |
| Disc Medicine, Inc.NasdaqGM: IRON | $3.16B | $82.41 | +1.82% |
| BioArctic AB (publ)OM: BIOA B | $3.14B | Skr335.60 | +5.01% |
| Arcutis Biotherapeutics, Inc.NasdaqGS: ARQT | $3.12B | $24.86 | +0.32% |
| Beam Therapeutics Inc.NasdaqGS: BEAM | $3.10B | $31.03 | +9.53% |
| ABL Bio Inc.KOSDAQ: A298380 | $3.04B | ₩75,200.00 | -10.58% |
| PharmaResearch Co., Ltd.KOSDAQ: A214450 | $3.00B | ₩400,500.00 | +0.63% |
| Yili Chuanning Biotechnology Co.,Ltd.SZSE: 301301 | $3.00B | CN¥9.02 | +1.46% |
| Keymed Biosciences Inc.SEHK: 2162 | $2.93B | HK$78.15 | -4.52% |
| Zai Lab LimitedNasdaqGM: ZLAB | $2.92B | $26.17 | +0.62% |
| SELLAS Life Sciences Group, Inc.NasdaqCM: SLS | $2.85B | $14.09 | -1.64% |
| Nurix Therapeutics, Inc.NasdaqGM: NRIX | $2.80B | $26.95 | +2.59% |
| Viridian Therapeutics, Inc.NasdaqCM: VRDN | $2.75B | $24.18 | -0.45% |
| Sinocelltech Group LimitedSHSE: 688520 | $2.65B | CN¥37.89 | -3.83% |
| CareDx, Inc.NasdaqGM: CDNA | $2.63B | $50.80 | +6.95% |
| Generate Biomedicines, Inc.NasdaqGS: GENB | $2.62B | $20.38 | +15.01% |
| Precigen, Inc.NasdaqGS: PGEN | $2.61B | $7.28 | +1.53% |
| Bavarian Nordic A/SCPSE: BAVA | $2.58B | Dkr218.20 | +2.44% |
| Vera Therapeutics, Inc.NasdaqGM: VERA | $2.54B | $35.28 | +4.63% |
| Ultragenyx Pharmaceutical Inc.NasdaqGS: RARE | $2.54B | $26.46 | +2.44% |
| BioCryst Pharmaceuticals, Inc.NasdaqGS: BCRX | $2.51B | $9.83 | +1.55% |
| Kodiak Sciences Inc.NasdaqGM: KOD | $2.48B | $39.46 | +6.02% |
| Lin BioScience, Inc.TPEX: 6696 | $2.44B | NT$939.00 | +2.96% |
| BGI Genomics Co., Ltd.SZSE: 300676 | $2.41B | CN¥42.20 | +3.84% |
| Hemab Therapeutics Holdings, Inc.NasdaqGS: COAG | $2.32B | $49.65 | +6.39% |
| Kailera Therapeutics, Inc.NasdaqGS: KLRA | $2.30B | $17.75 | +7.32% |
| Mineralys Therapeutics, Inc.NasdaqGS: MLYS | $2.27B | $26.34 | +2.73% |
| UroGen Pharma Ltd.NasdaqGM: URGN | $2.27B | $46.36 | +0.43% |
| Acrobiosystems Co.,Ltd.SZSE: 301080 | $2.24B | CN¥90.21 | +39.32% |
| Aurinia Pharmaceuticals Inc.NasdaqGM: AUPH | $2.23B | $16.75 | +1.09% |
| Duality Biotherapeutics, Inc.SEHK: 9606 | $2.22B | HK$192.60 | -1.28% |
| Vericel CorporationNasdaqGM: VCEL | $2.21B | $43.22 | +2.17% |
| Mesoblast LimitedASX: MSB | $2.20B | AU$2.36 | +6.79% |
| Xencor, Inc.NasdaqGM: XNCR | $2.18B | $29.30 | +1.05% |
| ADMA Biologics, Inc.NasdaqGM: ADMA | $2.18B | $9.72 | +1.78% |
| Biohaven Ltd.NYSE: BHVN | $2.17B | $14.38 | +5.12% |
| Pell Bio-Med Technology Co., Ltd.TWSE: 6949 | $2.17B | NT$1,070.00 | +12.87% |
| Shenzhen Kangtai Biological Products Co., Ltd.SZSE: 300601 | $2.16B | CN¥13.03 | +2.68% |
| Sino Biological,Inc.SZSE: 301047 | $2.15B | CN¥118.80 | -8.72% |
| Anhui Anke Biotechnology (Group) Co., Ltd.SZSE: 300009 | $2.14B | CN¥8.64 | +1.77% |
| Palvella Therapeutics, Inc.NasdaqGM: PVLA | $2.14B | $148.24 | +1.71% |
| Nanobiotix S.A.ENXTPA: NANO | $2.12B | €35.74 | +4.69% |
| Wuhan Healthgen Biotechnology Corp.SHSE: 688765 | $2.10B | CN¥39.63 | +1.82% |
| Genus plcLSE: GNS | $2.10B | £22.98 | +0.44% |
| Stoke Therapeutics, Inc.NasdaqGS: STOK | $2.08B | $33.46 | +3.62% |
| SK bioscience Co.,Ltd.KOSE: A302440 | $2.07B | ₩36,500.00 | -3.05% |
| COMPASS Pathways plcNasdaqGS: CMPS | $2.06B | $14.88 | +4.79% |
| Jinyu Bio-technology Co., Ltd.SHSE: 600201 | $2.05B | CN¥12.65 | -6.50% |
| Agios Pharmaceuticals, Inc.NasdaqGS: AGIO | $2.02B | $33.90 | +3.86% |
| Taysha Gene Therapies, Inc.NasdaqGS: TSHA | $2.02B | $6.20 | +3.85% |
| Sarepta Therapeutics, Inc.NasdaqGS: SRPT | $2.00B | $18.92 | +4.36% |
| D&D Pharmatech Inc.KOSDAQ: A347850 | $1.99B | ₩61,400.00 | +6.78% |
| Mabwell (Shanghai) Bioscience Co., Ltd.SHSE: 688062 | $1.98B | CN¥31.17 | -8.32% |
| Voronoi, Inc.KOSDAQ: A310210 | $1.98B | ₩152,100.00 | -15.36% |
| Zymeworks Inc.NasdaqGS: ZYME | $1.95B | $27.47 | -4.52% |
| Wedge Industrial Co.,Ltd.SZSE: 000534 | $1.94B | CN¥27.03 | -4.32% |
| Forte Biosciences, Inc.NasdaqCM: FBRX | $1.94B | $76.97 | +0.07% |
| Lakefront Biotherapeutics NVENXTAM: LKFT | $1.93B | €25.44 | +2.75% |
| Immunocore Holdings plcNasdaqGS: IMCR | $1.93B | $37.40 | +2.16% |
| Zenas BioPharma, Inc.NasdaqGS: ZBIO | $1.92B | $33.77 | +14.44% |
| Hugel, Inc.KOSDAQ: A145020 | $1.91B | ₩245,000.00 | -4.30% |
| Recursion Pharmaceuticals, Inc.NasdaqGS: RXRX | $1.91B | $3.56 | +9.54% |
| Damora Therapeutics, Inc.NasdaqCM: DMRA | $1.90B | $30.62 | -0.65% |
| Intellia Therapeutics, Inc.NasdaqGM: NTLA | $1.89B | $13.51 | +7.56% |
| BeBetter Med Inc.SHSE: 688759 | $1.88B | CN¥28.16 | +9.44% |
| Nanjing Vazyme Biotech Co., LtdSHSE: 688105 | $1.86B | CN¥24.24 | -2.92% |
| Nanjing Leads Biolabs Co., Ltd.SEHK: 9887 | $1.86B | HK$73.30 | +10.39% |
| Zhuhai Trinomab Pharmaceutical Co., Ltd.SHSE: 688806 | $1.85B | CN¥27.03 | -3.29% |
| Metis TechBio Co., Ltd.SEHK: 7666 | $1.83B | HK$12.11 | +0.92% |
| Idorsia LtdSWX: IDIA | $1.82B | CHF5.55 | -6.17% |
| CanSino Biologics Inc.SEHK: 6185 | $1.81B | HK$29.48 | +19.35% |
| Chengdu Olymvax Biopharmaceuticals Inc.SHSE: 688319 | $1.81B | CN¥30.05 | +5.29% |
| Vir Biotechnology, Inc.NasdaqGS: VIR | $1.81B | $10.71 | +8.07% |
| Inhibrx Biosciences, Inc.NasdaqGS: INBX | $1.81B | $122.72 | +16.94% |
| AlvotechNasdaqGM: ALVO | $1.80B | $5.05 | -3.81% |
| Syndax Pharmaceuticals, Inc.NasdaqGS: SNDX | $1.75B | $19.92 | +1.37% |
| AnaptysBio, Inc.NasdaqGS: ANAB | $1.73B | $58.37 | -0.12% |
| InventisBio Co., LimitedSHSE: 688382 | $1.72B | CN¥20.00 | -5.17% |
| Pharma Mar, S.A.BME: PHM | $1.70B | €83.85 | +1.88% |
| HBM Holdings LimitedSEHK: 2142 | $1.67B | HK$15.10 | +6.41% |
| Absci CorporationNasdaqGS: ABSI | $1.65B | $9.63 | +8.94% |
| Bicara Therapeutics Inc.NasdaqGM: BCAX | $1.63B | $24.58 | +4.24% |
| Yantai Dongcheng Pharmaceutical Group Co.,Ltd.SZSE: 002675 | $1.60B | CN¥13.04 | -0.99% |
| Hyperliquid Strategies Inc.NasdaqCM: PURR | $1.60B | $11.87 | +11.56% |
| Tyra Biosciences, Inc.NasdaqGS: TYRA | $1.59B | $26.69 | +2.30% |
| Staidson (Beijing) BioPharmaceuticals Co., Ltd.SZSE: 300204 | $1.58B | CN¥22.18 | -11.39% |
| First Tracks Biotherapeutics, Inc.NasdaqGS: TRAX | $1.57B | $44.04 | -2.85% |
| Jade Biosciences, Inc.NasdaqCM: JBIO | $1.57B | $21.84 | -11.61% |
| Novavax, Inc.NasdaqGS: NVAX | $1.56B | $9.44 | +6.55% |
| Hualan Biological Vaccine Inc.SZSE: 301207 | $1.55B | CN¥17.47 | +2.28% |
| ArriVent BioPharma, Inc.NasdaqGM: AVBP | $1.55B | $31.35 | +10.93% |
| Biotest GmbH & Co. KGaAHMSE: BIO0 | $1.54B | €33.40 | +0.60% |
| Ascentage Pharma Group InternationalSEHK: 6855 | $1.54B | HK$32.86 | -8.72% |
| Bonesupport Holding AB (publ)OM: BONEX | $1.52B | Skr224.40 | +2.65% |
| Pacific Shuanglin Bio-pharmacy Co., Ltd.SZSE: 000403 | $1.50B | CN¥10.63 | -2.48% |